Besides, integration of animal models, cellular functional assays, and multi-omics analyses will be essential to further elucidate the pathogenic mechanisms of ALMS1 variants, particularly their roles in cardiomyopathy, obesity, and hepatic injury, and to explore potential therapeutic targets and individualized treatment strategies. Here, ALMS1 is linked to cardiomyopathy.